• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Diabetes

ALR Technologies acquires Singapore-based CGM maker for $45M

June 30, 2026 By Sean Whooley

ALR Technologies Logo

ALR Technologies announced today that it entered into a letter of intent to acquire equity and assets of CGM Medical Technology. The Singapore-based company agreed to acquire 100% equity of CGM Medical Technology Singapore and assets of CGM Medical Technology Shenzhen. Its deal includes an aggregate purchase price of 200 million ordinary shares and $45 […]

Filed Under: Business/Financial News, Diabetes, Mergers & Acquisitions, Patient Monitoring, Technology Tagged With: Alrtechnologies

MiniMed adds Alcon CEO, Medtronic exec to board of directors

June 29, 2026 By Sean Whooley

Linnea Burman David Endicott MiniMed board

MiniMed (Nasdaq:MMED) announced today that it appointed David Endicott and Linnea Burman to its board of directors, effective today. The appointments of Endicott and Burman expand MiniMed’s board from nine members to 11 members. Endicott, currently the CEO of Alcon, also joins the board’s Compensation and Talent Committee with the appointment. Northridge, California-based MiniMed’s latest […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: minimed, Personnel Moves

Insulet adds new board director

June 25, 2026 By Sean Whooley

Jay Mazelsky IDEXX Insulet board (1)

Insulet (Nasdaq:PODD) announced today that it appointed Jonathan (“Jay”) Mazelsky to its board of directors, effective July 1. Mazelsky joins the Acton, Massachusetts-based automated insulin delivery technology developer‘s board as an independent director. “We are pleased to welcome Jay to Insulet’s board of directors,” said Insulet President and CEO Ashley McEvoy. “Jay has a strong […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Personnel Tagged With: Insulet, Personnel Moves

Anodyne picks up $12.6M to advance once-weekly GLP-1 patch

June 24, 2026 By Sean Whooley

Anodyne Nanotech microneedle GLP-1 patch

Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology. Velocity Partners VC led the round with co-leaders Evercurious VC, alongside major participation from Relativity Healthcare Partners. Boston-based Anodyne plans to use proceeds to support the advancement of ANN-101, its once-weekly GLP-1 patch for obesity. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: Anodyne Nanotech

Modular Medical launches Pivot tubeless insulin patch pump

June 24, 2026 By Sean Whooley

Modular Medical Pivot insulin patch pump in use

Modular Medical (Nasdaq:MODD) announced today that it commercially launched its new Pivot tubeless insulin patch pump. The rollout marks the start of real-world patient use of the Pivot pump. It marks San Diego-based Modular Medical’s transition to a commercial-stage medical device company. Modular Medical designed Pivot to make insulin pump therapy simpler to learn and […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: modularmedical

Dexcom launches enhanced Stelo app

June 23, 2026 By Sean Whooley

Dexcom Stelo user chops food

Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. The company At ADA 2026, Dexcom said it planned to offer select users the opportunity for early […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Technology Tagged With: Dexcom

MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe

June 23, 2026 By Sean Whooley

MiniMed 780G and Go systems lifestyle pics with Instinct sensor made by Abbott

MiniMed (Nasdaq:MMED) announced today that it launched two insulin delivery platforms with the Instinct sensor made by Abbott in Europe. The Northridge, California-based former Medtronic Diabetes unit launched its MiniMed 780G automated insulin delivery system integrated with Instinct, along with the MiniMed Go system paired with the Instinct Go sensor. Both sensors, made by Abbott […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: minimed

Insulet has a new chief R&D officer

June 22, 2026 By Sean Whooley

Divakar Ramakrishnan chief R&D officer Insulet

Insulet (Nasdaq:PODD) announced today on social media that it appointed Dr. Divakar Ramakrishnan as its new chief R&D officer. In a LinkedIn post, the company said Ramakrishnan will lead its R&D organization. His focus centers around strengthening Insulet’s capabilities in delivering innovation around the world. Ramakrishnan joins as the company continues to advance its automated […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel, Research & Development, Technology Tagged With: Insulet, Personnel Moves

MiniMed begins miniature Flex pump rollout in US

June 17, 2026 By Sean Whooley

MiniMed Flex insulin pump system product image

MiniMed (Nasdaq:MMED) announced today that it kicked off its first commercial launch of its Flex automated insulin delivery system in the U.S. The launch comes a few months after the system picked up FDA clearance in March. Northridge, California-based MiniMed, the former Medtronic Diabetes unit, designed Flex, its smallest insulin pump yet, as its first […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: minimed

FiberSense to bring new CGM to European market with CE mark

June 17, 2026 By Sean Whooley

FiberSense CGM CE mark

FiberSense announced today that it received CE mark approval for its continuous glucose monitoring (CGM) system. The FiberSense system is intended for the continuous monitoring of blood sugar levels and glucose trends in adults with diabetes. It uses advanced optical sensing technology to measure glucose concentrations in the tissue fluid beneath the skin (interstitial fluid). […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: FiberSense

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 203
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS